 STOCKHOLM, Jan. 16, 2023 PRNewswire Medivir AB Nasdaq Stockholm: MVIR, a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announces that the company will participate at the Redeye Fight Cancer Day on January 19, 2023. CEO Jens Lindberg will present the company and its plan for the ongoing ...... 